Trade Summary

6 days ago, BOBULSKY SUSAN, serving as Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT), sold 11,000 shares at $18.00 per share, for a total transaction value of $198,000.00. Following this transaction, BOBULSKY SUSAN now holds 416,775 shares of ADPT.

This sale represents a 2.57% decrease in BOBULSKY SUSAN's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 9, 2026 (accepted Jun 8, 8:27 PM ET), 5 days after the trade was made.

Adaptive Biotechnologies Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.